Woo K T, Lee E J, Lau Y K, Lim C H
Nephron. 1985;39(3):223-7. doi: 10.1159/000183376.
Plasma and urine beta-2-microglobulin (B2m) were measured in 37 renal transplant recipients and 34 healthy subjects. Serum B2m was found to be a more sensitive index of renal function than serum creatinine. Renal transplant recipients had significantly higher urine B2m when compared with normal controls. Normal subjects had a higher serum to urine B2m ratio (SUR) while those with renal impairment had a lower SUR. Serum B2m used alone or together with urine B2m and SUR appears a useful index for assessment of renal allograft function as well as detection of potential renal damage.
对37名肾移植受者和34名健康受试者测定了血浆和尿液中的β2微球蛋白(B2m)。发现血清B2m是比血清肌酐更敏感的肾功能指标。与正常对照组相比,肾移植受者的尿液B2m显著更高。正常受试者的血清与尿液B2m比值(SUR)更高,而肾功能受损者的SUR更低。单独使用血清B2m或与尿液B2m和SUR一起使用,似乎都是评估同种异体肾移植功能以及检测潜在肾损伤的有用指标。